glp-1 pregnancy From JAMA: #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja Navigating GLP-1 and Pregnancy: Insights,
Description
FDA approvals now encompass chronic kidney disease indications for some agents, obstructive sleep apnea treatment and metabolic dysfunction associated steatotic liver disease for select products
Ozempic/semaglutide is the one thats been all over the news lately, but look for mounjaro/tirzepatide coming down the pike
holds a James McGill Professor award from McGill University
Focus on compound movements with progressive overload
Itll balance access to the drug with guardrails, she said.
